There have been 50 recent insider transactions recorded for Edgewise Therapeutics, Inc. (EWTX), including 17 buys and 31 sells. Total insider buying was valued at $8.85M and total insider selling at $6.67M.
Notable insiders with recent activity include Donovan Joanne M., Fox Jonathan C, Edris Badreddin. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — EWTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Donovan Joanne M. |
CMO |
Informative Sell |
28,662 |
$32.31 |
$926.1K |
9,597 |
| 2026-04-01 |
Fox Jonathan C |
Director |
RSU Award |
339 |
- |
- |
24,514 |
| 2026-03-31 |
Donovan Joanne M. |
CMO |
Informative Sell |
21,338 |
$32.12 |
$685.31K |
9,597 |
| 2026-03-27 |
Donovan Joanne M. |
CMO |
Informative Sell |
6,735 |
$30.98 |
$208.64K |
9,597 |
| 2026-01-21 |
Edris Badreddin |
Director |
Option Exercise (Sell) |
13,690 |
$0.39 |
$5.34K |
- |
| 2026-01-02 |
Fox Jonathan C |
Director |
RSU Award |
473 |
- |
- |
24,175 |
| 2025-11-19 |
Martin Christopher Nathan |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-19 |
Martin Christopher Nathan |
Director |
RSU Award |
45,150 |
$22.34 |
$1.01M |
45,150 |
| 2025-11-12 |
Russell Alan J |
Chief Scientific Officer |
Informative Sell |
100,000 |
$21.12 |
$2.11M |
23,400 |
| 2025-11-11 |
Fox Jonathan C |
Director |
Informative Buy |
10,700 |
$18.64 |
$199.4K |
23,702 |
| 2025-11-10 |
Nofi Michael |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-10 |
Nofi Michael |
Chief Financial Officer |
RSU Award |
43,750 |
- |
- |
43,750 |
| 2025-10-01 |
Fox Jonathan C |
Director |
RSU Award |
728 |
- |
- |
13,002 |
| 2025-08-26 |
Russell Alan J |
Chief Scientific Officer |
Informative Sell |
100,000 |
$14.60 |
$1.46M |
23,400 |
| 2025-08-12 |
Koch Kevin |
President and CEO |
Informative Sell |
7,972 |
$13.39 |
$106.76K |
30,615 |
| 2025-08-12 |
Moore John R |
General Counsel |
Informative Sell |
2,098 |
$13.39 |
$28.1K |
10,214 |
| 2025-08-12 |
Donovan Joanne M. |
CMO |
Option Exercise (Sell) |
5,781 |
- |
- |
17,344 |
| 2025-08-12 |
Carruthers R Michael |
Chief Financial Officer |
Option Exercise (Sell) |
5,781 |
- |
- |
17,344 |
| 2025-08-12 |
Derakhshan Behrad |
Chief Business Officer |
Option Exercise (Sell) |
5,781 |
- |
- |
17,344 |
| 2025-08-12 |
Russell Alan J |
Chief Scientific Officer |
Option Exercise (Sell) |
5,781 |
- |
- |
17,344 |
| 2025-08-12 |
Blaustein Robert |
Chief Development Officer |
RSU Award |
17,500 |
- |
- |
17,500 |
| 2025-07-01 |
Fox Jonathan C |
Director |
RSU Award |
858 |
- |
- |
12,274 |
| 2025-06-16 |
Root Jonathan D |
Director |
RSU Award |
30,000 |
$14.68 |
$440.4K |
30,000 |
| 2025-06-16 |
Thompson Peter A. |
10 Percent Owner |
RSU Award |
30,000 |
$14.68 |
$440.4K |
30,000 |
| 2025-06-16 |
Morris Arlene |
Director |
RSU Award |
30,000 |
$14.68 |
$440.4K |
30,000 |
| 2025-06-16 |
Brege Laura |
Director |
RSU Award |
30,000 |
$14.68 |
$440.4K |
30,000 |
| 2025-06-16 |
Fox Jonathan C |
Director |
RSU Award |
30,000 |
$14.68 |
$440.4K |
30,000 |
| 2025-06-16 |
Edris Badreddin |
Director |
RSU Award |
30,000 |
$14.68 |
$440.4K |
30,000 |
| 2025-05-02 |
Koch Kevin |
President and CEO |
Informative Sell |
4,276 |
$16.45 |
$70.36K |
20,619 |
| 2025-05-02 |
Moore John R |
General Counsel |
Informative Sell |
1,930 |
$16.45 |
$31.76K |
6,531 |
| 2025-05-02 |
Donovan Joanne M. |
CMO |
Informative Sell |
5,187 |
$16.45 |
$85.35K |
21,588 |
| 2025-05-02 |
Carruthers R Michael |
Chief Financial Officer |
Informative Sell |
1,314 |
$16.45 |
$21.62K |
81,014 |
| 2025-05-02 |
Derakhshan Behrad |
Chief Business Officer |
Informative Sell |
1,691 |
$16.45 |
$27.82K |
20,355 |
| 2025-05-02 |
Russell Alan J |
Chief Scientific Officer |
Informative Sell |
1,551 |
$16.45 |
$25.52K |
18,521 |
| 2025-05-01 |
Koch Kevin |
President and CEO |
Option Exercise (Sell) |
10,417 |
- |
- |
- |
| 2025-05-01 |
Moore John R |
General Counsel |
Option Exercise (Sell) |
5,209 |
- |
- |
- |
| 2025-05-01 |
Donovan Joanne M. |
CMO |
Option Exercise (Sell) |
10,417 |
- |
- |
- |
| 2025-05-01 |
Carruthers R Michael |
Chief Financial Officer |
Option Exercise (Sell) |
5,209 |
- |
- |
- |
| 2025-05-01 |
Derakhshan Behrad |
Chief Business Officer |
Option Exercise (Sell) |
5,209 |
- |
- |
- |
| 2025-05-01 |
Russell Alan J |
Chief Scientific Officer |
Option Exercise (Sell) |
5,209 |
- |
- |
- |
| 2025-04-03 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Buy |
124,193 |
$20.13 |
$2.5M |
443,792 |
| 2025-04-03 |
Thompson Peter A. |
10 Percent Owner |
Informative Buy |
124,193 |
$20.13 |
$2.5M |
443,792 |
| 2025-04-01 |
Fox Jonathan C |
Director |
RSU Award |
559 |
- |
- |
11,416 |
| 2025-03-07 |
Koch Kevin |
President and CEO |
Informative Sell |
100 |
$30.00 |
$3K |
14,478 |
| 2025-03-07 |
Russell Alan J |
Chief Scientific Officer |
Informative Sell |
200 |
$30.02 |
$6K |
14,863 |
| 2025-02-06 |
Koch Kevin |
President and CEO |
Informative Sell |
900 |
$31.13 |
$28.02K |
14,478 |
| 2025-02-06 |
Russell Alan J |
Chief Scientific Officer |
Informative Sell |
1,200 |
$30.13 |
$36.15K |
14,863 |
| 2025-02-05 |
Koch Kevin |
President and CEO |
Informative Sell |
8,636 |
$30.03 |
$259.3K |
14,478 |
| 2025-02-05 |
Derakhshan Behrad |
Chief Business Officer |
Informative Sell |
10,000 |
$30.03 |
$300.3K |
16,837 |
| 2025-02-05 |
Russell Alan J |
Chief Scientific Officer |
Informative Sell |
8,015 |
$30.02 |
$240.62K |
14,863 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
